France · Delayed Price · Currency is EUR LNA Santé Statistics
Total Valuation
LNA Santé has a market cap or net worth of EUR 254.30 million. The enterprise value is 1.11 billion.
| Market Cap | 254.30M |
| Enterprise Value | 1.11B |
Important Dates
The last earnings date was Wednesday, September 16, 2026.
| Earnings Date | Sep 16, 2026 |
| Ex-Dividend Date | Jul 8, 2026 |
Share Statistics
LNA Santé has 10.30 million shares outstanding. The number of shares has increased by 0.33% in one year.
| Current Share Class | 10.30M |
| Shares Outstanding | 10.30M |
| Shares Change (YoY) | +0.33% |
| Shares Change (QoQ) | +0.33% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 12.57% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 10.02 and the forward PE ratio is 8.30.
| PE Ratio | 10.02 |
| Forward PE | 8.30 |
| PS Ratio | 0.27 |
| PB Ratio | 0.74 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 2.87 |
| P/OCF Ratio | 2.58 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.96, with an EV/FCF ratio of 12.57.
| EV / Earnings | 43.99 |
| EV / Sales | 1.17 |
| EV / EBITDA | 6.96 |
| EV / EBIT | 14.67 |
| EV / FCF | 12.57 |
Financial Position
The company has a current ratio of 0.87, with a Debt / Equity ratio of 2.74.
| Current Ratio | 0.87 |
| Quick Ratio | 0.44 |
| Debt / Equity | 2.74 |
| Debt / EBITDA | 5.90 |
| Debt / FCF | 10.61 |
| Interest Coverage | 2.49 |
Financial Efficiency
Return on equity (ROE) is 8.04% and return on invested capital (ROIC) is 4.06%.
| Return on Equity (ROE) | 8.04% |
| Return on Assets (ROA) | 2.91% |
| Return on Invested Capital (ROIC) | 4.06% |
| Return on Capital Employed (ROCE) | 6.58% |
| Weighted Average Cost of Capital (WACC) | 3.11% |
| Revenue Per Employee | 105,865 |
| Profits Per Employee | 2,823 |
| Employee Count | 10,000 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 3.39 |
Taxes
In the past 12 months, LNA Santé has paid 14.92 million in taxes.
| Income Tax | 14.92M |
| Effective Tax Rate | 35.60% |
Stock Price Statistics
The stock price has decreased by -3.89% in the last 52 weeks. The beta is 0.50, so LNA Santé's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | -3.89% |
| 50-Day Moving Average | 32.48 |
| 200-Day Moving Average | 29.70 |
| Relative Strength Index (RSI) | 24.00 |
| Average Volume (20 Days) | 6,517 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LNA Santé had revenue of EUR 950.25 million and earned 25.34 million in profits. Earnings per share was 2.47.
| Revenue | 950.25M |
| Gross Profit | 263.56M |
| Operating Income | 75.23M |
| Pretax Income | 41.90M |
| Net Income | 25.34M |
| EBITDA | 99.33M |
| EBIT | 75.23M |
| Earnings Per Share (EPS) | 2.47 |
Balance Sheet
The company has 89.43 million in cash and 940.41 million in debt, with a net cash position of -850.98 million or -82.65 per share.
| Cash & Cash Equivalents | 89.43M |
| Total Debt | 940.41M |
| Net Cash | -850.98M |
| Net Cash Per Share | -82.65 |
| Equity (Book Value) | 342.81M |
| Book Value Per Share | 32.40 |
| Working Capital | -68.39M |
Cash Flow
In the last 12 months, operating cash flow was 98.54 million and capital expenditures -9.88 million, giving a free cash flow of 88.66 million.
| Operating Cash Flow | 98.54M |
| Capital Expenditures | -9.88M |
| Depreciation & Amortization | 24.10M |
| Net Borrowing | -17.64M |
| Free Cash Flow | 88.66M |
| FCF Per Share | 8.61 |
Margins
Gross margin is 27.74%, with operating and profit margins of 7.92% and 2.67%.
| Gross Margin | 27.74% |
| Operating Margin | 7.92% |
| Pretax Margin | 4.41% |
| Profit Margin | 2.67% |
| EBITDA Margin | 10.45% |
| EBIT Margin | 7.92% |
| FCF Margin | 9.33% |
Dividends & Yields
This stock pays an annual dividend of 0.95, which amounts to a dividend yield of 3.85%.
| Dividend Per Share | 0.95 |
| Dividend Yield | 3.85% |
| Dividend Growth (YoY) | 46.15% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 26.33% |
| FCF Payout Ratio | 11.03% |
| Buyback Yield | -0.33% |
| Shareholder Yield | 3.52% |
| Earnings Yield | 9.96% |
| FCF Yield | 34.86% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for LNA Santé is 41.10, which is 66.40% higher than the current price. The consensus rating is "Buy".
| Price Target | 41.10 |
| Price Target Difference | 66.40% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 6.66% |
| EPS Growth Forecast (3Y) | 17.68% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LNA Santé has an Altman Z-Score of 0.81 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.81 |
| Piotroski F-Score | 6 |